Aisling Capital IV, LP - Jun 29, 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
10%+ Owner
Signature
AISLING CAPITAL IV, LP, by Aisling Capital Partners IV, LP, its General Partner, by Aisling Capital Partners IV LLC, its General Partner, /s/ Andrew Schiff, Managing Member
Stock symbol
ELEV
Transactions as of
Jun 29, 2021
Transactions value $
$3,000,000
Form type
4
Date filed
7/1/2021, 06:29 PM
Previous filing
Jun 24, 2021
Next filing
Jun 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELEV Common Stock Conversion of derivative security $0 +1.89M +640% $0.00 2.19M Jun 29, 2021 Direct F1, F2
transaction ELEV Common Stock Conversion of derivative security $0 +458K +20.94% $0.00 2.65M Jun 29, 2021 Direct F1, F2
transaction ELEV Common Stock Purchase $3M +188K +7.08% $16.00* 2.83M Jun 29, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Series A Preferred Stock Conversion of derivative security $0 -8M -100% $0.00* 0 Jun 29, 2021 Common Stock 1.89M Direct F1, F2
transaction ELEV Series B Preferred Stock Conversion of derivative security $0 -1.94M -100% $0.00* 0 Jun 29, 2021 Common Stock 458K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date.
F2 The securities are directly held by Aisling Capital IV, LP ("Aisling"). Aisling Capital Partners IV, LP ("Aisling GP"), is the general partner of Aisling, and Aisling Capital Partners IV LLC ("Aisling Partners"), is the general partner of Aisling GP. The managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms and may share voting power and dispositive powers over securities held by Aisling, and as a result, may be deemed to have beneficial ownership over such securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.